C section News and Research

RSS

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

30 Jul 2010

Omeros secures committed equity financing facility

Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use the facility and remains free to enter into and consummate other equity, debt and non-dilutive financing transactions. Omeros intends to use the proceeds from future sales of securities under the facility, if any, for general corporate purposes.

29 Jul 2010

NMF raises $30,000 in 30 days to help women have gynecologic surgery

Natividad Medical Foundation President & CEO Linda Ford announced NMF has raised $30,000 in 30 days – enough for about 12 women to have the gynecologic surgery they so desperately need. The announcement is part of the launch of The Onyx Fund for Women – named in honor of a Natividad Medical Center patient named Onix who inspired a hospital's doctors and a philanthropic fund.

29 Jul 2010

Mapping NTDs is critical for controlling, treating diseases

Mapping neglected tropical diseases (NTDs) is vital for efforts to control and treat diseases, write the authors of an editorial published Tuesday in PLoS Neglected Tropical Diseases, ANI/Sindh Today reports (7/28).

29 Jul 2010

Cancer survivor to celebrate 100th birthday

Loyola University Hospital cancer patient Mary Cipolla was 89 years old when she underwent one of the most extensive operations in surgery, known as the Whipple procedure.

28 Jul 2010

Cell Therapeutics closes $4.06 million private offering

Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.

28 Jul 2010

HealthStream second-quarter revenues increase 14% to $16.7M

HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, announced today results for the second quarter ended June 30, 2010.

27 Jul 2010

AIDS 2010 opinions: U.S. funding for global HIV/AIDS programs; Empowering women, girls in fight against HIV/AIDS

The first letter, Ambassador Eric Goosby, U.S. Global AIDS Coordinator, addresses an opinion piece by Desmond Tutu, archbishop emeritus of Cape Town and honorary chairman of the Global AIDS Alliance. Goosby writes, "The United States has been and continues to be the global leader on HIV/AIDS. The best metric of our success is lives saved." Goosby cites an increased number of people on antiretrovirals financed by the United States and a commitment to treat 4 million more as part of the Global Health Initiative.

27 Jul 2010

Study compares current state of healthcare system in UK and proposed system in US

A comparison of the current state of the healthcare system in the UK and the new system proposed under legislation pushed through by Barack Obama's government, shows some surprising results. The review is published in the Journal of the Royal Society of Medicine (JRSM).

26 Jul 2010

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Boehringer Ingelheim announced today that the European Committee for Medicinal Products for Human Use (CHMP) adopted a Positive Opinion for the approval of TWYNSTA®. It will be indicated in adults whose blood pressure is not adequately controlled on amlodipine and is also indicated as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of TWYNSTA containing the same component doses.

26 Jul 2010

It's back: House Democrats argue anew for public option

House Democrats are arguing again for the passage of a public option to compete with private health plans and reduce the deficit, news outlets report.

26 Jul 2010

Cell Therapeutics agrees to sell 4,060 shares of Series 6 preferred stock

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.

26 Jul 2010

New data on health insurance to be included in AHRQ's 2009 State Snapshots

The Agency for Healthcare Research and Quality's annual release of state-by-state quality data has been expanded to include new data on health insurance, including data on health care quality categorized by source of payment, including private insurance, Medicare, Medicaid and those without insurance.

23 Jul 2010

Study identifies infection mechanism of disease-causing microbes

A study published in the July 23 issue of Cell identifies the mechanism used by several types of common, virulent microbes to infect plants and cause devastating blights. Microbes using this infection mechanism include fungi that are currently causing wheat rust epidemics in Africa and Asia, and a class of parasitic algae, called oomycetes, that resulted in the Irish potato blight of the 19th Century. These microbes remain an agricultural scourge today.

23 Jul 2010

Repetition of DRD4 genotype may increase risk for extensive alcohol use

Your friend walks into a bar to meet you for happy hour. He sidles up to the bar and orders a drink - does that make you more likely to get a drink yourself? According to new findings reported in Psychological Science, a journal of the Association for Psychological Science, genetics may determine the extent to which you are influenced by social drinking cues - signals such as advertisements, drinks placed on a bar, and seeing other people around you drinking.

23 Jul 2010

athenahealth second-quarter total revenue increases 28% to $58.6M

athenahealth, Inc., a leading provider of web-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced financial and operational results for the second quarter of fiscal year 2010. The Company will conduct a conference call on Friday, July 23, 2010, at 8:00 a.m. Eastern Time to discuss these results and management's outlook for future financial and operational performance.

23 Jul 2010

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.

22 Jul 2010

Physicians Practice, Wolfson Children's Hospital to help doctors manage patient care in Jacksonville area

Physicians Practice and Wolfson Children's Hospital have joined forces to help provide area physicians and their staff more time to devote to patient care. This new partnership is a unique program designed to help doctors in the Jacksonville area better handle the cumbersome and time-consuming issues of managing a busy practice.

22 Jul 2010

Vaginal birth after previous C-section may be a safe option say doctors

According to new practice guidelines revealed for obstetricians by the American College of Obstetricians and Gynecologists this Wednesday, a vaginal birth after a Caesarean section (VBAC) or maybe even after two C-sections can be a safe and appropriate choice.

21 Jul 2010

Spindly extensions of bone cells sense mechanical stimulation and signal release of bone-growth factors

A long-standing question in bone biology has been answered: It is the spindly extensions of bone cells that sense mechanical stimulation and signal the release of bone-growth factors, according to research from The University of Texas Health Science Center at San Antonio.

21 Jul 2010